Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Reexamination Certificate
2008-01-03
2011-11-22
Haghighatian, Mina (Department: 1616)
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
C424S046000, C128S200140
Reexamination Certificate
active
08062626
ABSTRACT:
The invention relates to ethanol-containing pharmaceutical preparations for the production of propellant-free aerosols.
REFERENCES:
patent: 4289764 (1981-09-01), Yarrow
patent: 4383992 (1983-05-01), Lipari
patent: 4450151 (1984-05-01), Shinozawa
patent: 4615699 (1986-10-01), Gale et al.
patent: 4857312 (1989-08-01), Hegasy et al.
patent: 4919919 (1990-04-01), Aouda et al.
patent: 5047230 (1991-09-01), Nagy et al.
patent: 5136124 (1992-08-01), Cronin et al.
patent: 5225183 (1993-07-01), Purewal et al.
patent: 5370862 (1994-12-01), Klokkers-Bethke et al.
patent: 5474759 (1995-12-01), Fassberg et al.
patent: 5674471 (1997-10-01), Akehurst et al.
patent: 5736124 (1998-04-01), Akehurst et al.
patent: 5776432 (1998-07-01), Schultz et al.
patent: 5914122 (1999-06-01), Otterbeck et al.
patent: 5958378 (1999-09-01), Waldrep et al.
patent: 6004537 (1999-12-01), Blondino et al.
patent: 6039932 (2000-03-01), Govind et al.
patent: 6491897 (2002-12-01), Freund et al.
patent: 6890517 (2005-05-01), Drechsel et al.
patent: 3246081 (1984-06-01), None
patent: 195 23 207 (1986-01-01), None
patent: 4123663 (1993-01-01), None
patent: 44 46 891.1 (1996-07-01), None
patent: 0234 500 (1987-09-01), None
patent: 0310910 (1989-04-01), None
patent: 0468555 (1992-01-01), None
patent: 0504112 (1992-09-01), None
patent: 0605578 (1994-07-01), None
patent: 970027 (1964-09-01), None
patent: 1525181 (1978-09-01), None
patent: 82/03172 (1982-09-01), None
patent: 90/06750 (1990-06-01), None
patent: 92/06675 (1992-04-01), None
patent: 93/05765 (1993-04-01), None
patent: 93/15715 (1993-08-01), None
patent: 93/15741 (1993-08-01), None
patent: 94/13262 (1994-06-01), None
patent: 95/14474 (1995-06-01), None
patent: 96/19969 (1996-07-01), None
patent: 97/01329 (1997-01-01), None
C. Monder, Stability of Corticosteroids in Aqueous Solutions, Endocrinology, vol. 82, 1968, pp. 318-326.
M. Nyman-Pantelidis et al., Pharmacokinetics and retrograde colonic spread of budesonide enemas in patients with distal ulcerative colitis, Alimentary Pharmacology & Therapeutics, Bol. 8, 1994, pp. 617-622.
Declaration by Hans Nilsson regarding the matter of European Patent No. 0 794 767-regarding the manufacture and public availability of Rhinocort Aqua: before 1994, In the name of Dr. Falk Pharma GmbH and Opposition thereto by Astra AB.
Declaration by Anders Akerlund, regarding the matter of European Patent No. 0 794 767-regarding the public availability of Rhinocort Aqua: before 1994, In the name of Dr. Falk Pharma GmbH and Opposition thereto by Astra AB.
Monograph Entocort, Oxford Clinical Communications 1992, First Update and Reprint 1995.
Title page and page 1 from Laekartidningen, vol. 22, 1987.
Letter from “Laekemedelsverket” regarding public availability and the date of publication of the Composition of “Rhinocort Aqua” before Jun. 13, 1986.
Patent Abstracts of Japan, vol. 5, No. 136 [808], Aug. 28, 1981; & JP-56071046 A (Nippon Kayaku K.K.) Jun. 13, 1981.
Chem. Abstract, vol. 10 No. 252 JP 61-83117 (A) Apr. 26, 1986.
Dahlbaeck, M, et al, Inhalation of Glucocorticoid Particles (GCS) (Budesonide) to the Rat Lung, to Prevent Lung Edema Formation, J. Aerosols in Science, Medicine and Technology (1984) vol. 15, No. 3, 0. 218-219.
Williams S.J., et al, Bronchodilator effect of Deltal-tetrahydrocannabinol administered by aerosol to asthmatic patents. Thorax (1976), vol. 31, No. 6 pp. 720-723.
Davis, S.S., et al, Physico-Chemical Studies on Aerosol Solutions for Drug Delivery II. Water-Propylene Glycol-Ethanol Systems. Int. J. of Pharmaceutics, (1978) vol. 1, No. 2, pp. 85-93.
Timmins and Gray, The degradation of triamcinolone acetonide in aqueous solution: influence of the cyclic ketal function. J. Pharm.Pharmacol, 1983, vol. 35, pp. 175-177.
Das Gupta, V., Stability of Triamcinolone Acetonide Solutions as Determined by High-Performance Liquid Chromatography. (1983), vol. 72, No. 12, pp. 1453-1456.
Derbacher & Zimmermann, Physikalische Eigenschaften von Inhalationsloesungen. Atemwegs und Lungenkrankheiten, 1994, vol. 20 No. 7, pp. 381-382.
Hansen & Bundgaard, Studies on the stability of corticosteroids. Arch. Pharm Chemi. Sci. Ed. 7, 1979, pp. 135-146.
H. Nolen III, et al., Budesonide-Beta-D-glucuronide: A Potential Prodrug for Treatment of Ulcerative Colitis. J. Pharm. Sci., 1995, vol. 84, No. 6 pp. 677-681.
C. Lamers, et al., Comparative study of the topically acting glucocorticosteroid budesonide and 5-aminosalicylic acid enema therapy of proctitis and proctosigmoiditis. Gastroenterology 1991, 100, A223.
A. Danielsson, et al., A Controlled Randomized Trial of Budesonide versus Prednisolone Retention Enemas in Active Distal Ulcerative Colitis. Scand. J. Gastroenterol., 1987 vol. 22 pp. 987-992.
The Danish Budesonide Study Group, “Budesonide Enema in Distal Ulcerative Colitis”. Scand. J. Gastroentrol., 1991, vol. 26, pp. 1225-1230.
G. B. Porro, et al., “Comparative trial of methylprednisolone and budesonide enemas in active distal ulcerative colitis”. Eur. J. Gastroenterol., 1994, vol. 6, pp. 125-130.
Advertisement in Laekartidningen, No. 22/87 dated May 27, 1987 for Rhinocort(R) Aqua and English translation thereof.
“The official document for the Composition Data for Rhinocort(R)” aqua dated Mar. 5, 1987 and English translation thereof.
N. Linnet, “pH Measurements in Theory and Practice”. Radiometer A/S, Copenhagen 1970, pp. 94-96.
“L'Informatatore Farmaceutico”, Annuario Italiano Dei Medicamenti E Dei Laboratori Italian Directory of Drugs and Manufactures, 1993 , vol. 1, 53rd edition, p. 105.
Dekker & Beijnen, “Effects of Substituents in Dihydroxy-acetone Side chain Containing Corticosteroids on the Anerobic Steroid Decomposition.” Pharm. Acta Helv. 1982, vol. 57, No. 1, pp. 4-7.
D. M. Johnson, “Degradation of Cloprendol in Aqueous Solution. The Enolization Step,” J. Org. Chem., 1982 vol. 47, pp. 198-201.
Hansen & Bundgaard “Studies on the stability of corticosteroids v. the degradation pattern of hydrocortisone in aqueous solution”, pp. 307-319, 1980.
Amin & Bryan, “Kinetics and Factors Affecting Stability of Methylprednisolone in Aqueous Formulation,” Journal of Pharmaceutical Sciences, No. 1973, vol. 62, No. 11, pp. 1768-1771.
Freund Bernhard
Krueger Michael
Zierenberg Bernd
Boehringer Ingelheim KG
Devlin Mary-Ellen M.
Haghighatian Mina
Morris Michael P.
LandOfFree
Stable pharmaceutical budesonide preparation for producing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable pharmaceutical budesonide preparation for producing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable pharmaceutical budesonide preparation for producing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4280568